Business
AIM Rule 17 and Schedule 2(g) Update
AIM Rule 17 and Schedule 2(g) Update.
About this update from Physiomics Plc
[{"type":"text","content":"\n\n7 May 2025\n \nPhysiomics plc\n(\"Physiomics\" or the \"Company\")\n \nUpdate re: AIM Rule 17 - Schedule Two (g) Director's Disclosure\n \nPhysiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, provides the following update in accordance with AIM Rule 17 and Schedule Two(g) sub-paragraph (v) of the AIM Rules for Companies:\nDr. Timothy Corn, a Non-Executive Director of the Company, is an Executive Director of Oxford Cannabinoid Technologies Holdings plc (\"OCT\"), a public company incorporated in England and Wales, having been appointed to this role in November 2023. On 2 May 2025, OCT was placed into administration.\n \nFor more information about Physiomics and its services, please visit www.physiomics.co.uk.\n \nEnquiries:\n \nPhysiomics plc\nDr Peter Sargent, CEO\n+44 (0)1235 841575\n \nHybridan LLP (Broker)\nClaire Louise Noyce\n+44 (0) 203 764 2341\n \nStrand Hanson Ltd (NOMAD)\nJames Dance & James Bellman\n+44 (0)20 7409 3494\n \n \nNotes to Editor\n \nAbout Physiomics\n \nPhysiomics plc combines expertise across Modelling & Simulation, Biostatistics, Data Science and Bioinformatics, together with deep biology expertise, to help biotech and pharma companies streamline their drug development journeys. Our approach is to help derive insight from all relevant and often disparate data in order to de-risk decision making and optimise research design across discovery, pre-clinical and clinical studies. Through use of cutting-edge computational tools, bespoke models and our proprietary Virtual Tumour technology, the Physiomics team has informed the development of over 100 commercial projects, with over 125 targets and drugs modelled. Clients include Merck KGaA, Astellas, Bicycle Therapeutics, Numab Therapeutics & CRUK. \n \n \n\n","length":4165,"tagName":"div"}]